]>Chronic Brucellosis Patients Retain Low Frequency of CD4+ T-Lymphocytes Expressing CD25 and CD28 after <i>Escherichia coli</i> LPS Stimulation of PHA-Cultured PBMCs : Table 3
Table 3: Percentage of CD4+/CD25+, CD4+/CD28+ lymphocytes, and CD80+ cells of CD14+ population, in PHA-cultures with (a) E. coli LPS and (b) HKBA (results are presented as mean  ±  SD). NS: nonsignificant.

(a) E. coli LPS culturesn %CD4+/CD25+ %CD4+/CD28+ %CD14+/CD80+

AB 13 3 7 . 2 ± 1 1 . 6 4 3 . 4 ± 1 1 . 3 4 7 . 9 ± 1 9 . 9
CB 22 2 7 . 9 ± 6 . 9 3 5 . 7 ± 8 . 0 4 5 . 9 ± 2 3 . 2
Cured 11 3 0 . 8 ± 1 2 . 8 3 9 . 8 ± 1 7 . 2 2 1 . 8 ± 1 4 . 4
Controls 15 2 7 . 4 ± 1 0 . 5 3 6 . 5 ± 1 4 . 9 2 0 . 9 ± 1 2 . 5

P (AB versus cured)  =  NSP (AB versus cured)  =  NSP(AB versus cured)  =  .002
P (AB versus controls)  =  .027P (AB versus controls)  =  NSP (AB versus controls)  <  .001
P (CB versus cured)  =  NSP (CB versus cured)  =  NSP (CB versus cured)  =  .001
P (CB versus controls)  =  NSP (CB versus controls)  =  NSP (CB versus controls)  <  .001
P (AB versus CB)  =  .006P (AB versus CB)  =  .024P (AB versus CB)  =  NS

CB1 12 2 6 . 3 ± 5 . 9 3 4 . 5 ± 8 . 7 4 9 . 9 ± 2 6 . 5
CB2 10 2 9 . 9 ± 7 . 9 3 7 . 1 ± 7 . 2 4 1 . 1 ± 1 8 . 7

P (CB1 versus AB)  =  .008P (CB1 versus AB)  =  .039P (CB1 versus CB2)  =  NS
P (CB1 versus controls)  =  .003
P (CB2 versus controls)  =  .004

(b)HKBA cultures

AB 13 2 2 . 4 ± 1 1 . 5 3 5 . 9 ± 1 4 . 5 3 0 . 0 ± 2 0 . 8
CB 22 2 4 . 8 ± 6 . 5 3 8 . 8 ± 1 1 . 2 3 6 . 5 ± 2 5 . 5
Cured 11 2 4 . 8 ± 1 4 . 8 3 8 . 7 ± 1 7 . 9 2 0 . 9 ± 1 6 . 7
Controls 15 2 0 . 6 ± 1 0 . 3 3 5 . 6 ± 1 6 . 9 1 6 . 3 ± 1 3 . 6

NSNSP (AB versus controls)  =  .047
P (CB versus controls)  =  .004

CB1 12 2 4 . 9 ± 7 . 6 3 8 . 3 ± 1 3 . 3 4 6 . 6 ± 2 6 . 6
CB2 10 2 4 . 7 ± 5 . 1 3 9 . 3 ± 8 . 7 2 4 . 4 ± 1 8 . 7

NSNSP (CB1 versus CB2)  =  .038
P (CB1 versus cured)  =  .012
P (CB1 versus controls)  =  .003